跳转至内容
Merck
CN
所有图片(1)

文件

662005

Sigma-Aldrich

U0126

≥98% (HPLC), solid, MEK inhibitor, Calbiochem®

别名:

U0126, 1,4-二氨基-2,3-二氰基-1,4-(2-氨基苯巯基)丁二烯,d,MEK抑制剂VI

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C18H16N6S2 · 0.5C2H6O
分子量:
403.52
UNSPSC代码:
12352200
NACRES:
NA.77

product name

U0126, U0126, CAS 109511-58-2, is a potent and specific inhibitor of MEK1 (IC₅₀ = 72 nM) and MEK2 (IC₅₀ = 58 nM). The inhibition is noncompetitive with respect to both ATP and ERK.

质量水平

检测方案

≥98% (HPLC)

形式

solid

制造商/商品名称

Calbiochem®

储存条件

OK to freeze
protect from light

颜色

white

溶解性

DMSO: 200 mg/mL

运输

ambient

储存温度

−20°C

InChI

1S/C18H16N6S2/c19-9-11(17(23)25-15-7-3-1-5-13(15)21)12(10-20)18(24)26-16-8-4-2-6-14(16)22/h1-8H,21-24H2/b17-11+,18-12+

InChI key

DVEXZJFMOKTQEZ-JYFOCSDGSA-N

一般描述

MEK1(IC50=72 nM)和MEK2(IC50=58 nM)的有效和特异性抑制剂。这种抑制对ATP和ERK都是非竞争性的。对其他激酶如Abl、Cdk2、Cdk4、ERK、JNK、MEKK、MKK-3、MKK-4/SEK、MKK-6、PKC和Raf几乎没有影响。显示可阻断多沙唑嗪诱导的成骨细胞分化。也可作为免疫抑制剂,有效阻断IL-2合成和T细胞增殖,而不影响T细胞活化或耐受的长期结果。对于ATP没有竞争性。也可提供InSolution格式(目录号662009)。
MEK1(IC50=72 nM)和MEK2(IC50=58 nM)的有效和特异性抑制剂。这种抑制对MEK底物、ATP和ERK是非竞争性的。对其他激酶如Abl、Cdk2、Cdk4、ERK、JNK、MEKK、MKK-3、MKK-4/SEK、MKK-6、PKC和Raf几乎没有影响。显示可阻断多沙唑嗪诱导的成骨细胞分化。U0126还可作为免疫抑制剂,有效阻断IL-2合成和T细胞增殖,而不影响T细胞活化或耐受的长期结果。对于ATP没有竞争性。也可提供InSolution格式(目录号662009。

生化/生理作用

主靶
MEK1和MEK2
产物不与ATP竞争。
可逆:否
细胞可渗透性:否
靶标IC50:针对MEK1和MEK2分别为72和58nM。

包装

用惰性气体包装

警告

毒性:标准处理(A)

重悬

溶液中不稳定;仅在使用前进行复溶。

其他说明

Choi, Y.J., et al. 2011.Biochem.Biophys.Res. Commun.416, 232.
DeSilva, D.R., et al. 1998.J. Immunol. 160, 4175.
Duncia, J.V., et al. 1998.Biorg.Med. Chem. Lett.8, 2839.
Favata, M.F., et al. 1998.J. Biol. Chem. 273, 18623.

法律信息

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

WGK

WGK 2

闪点(°F)

Not applicable

闪点(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Gil-Ran Kim et al.
Advanced science (Weinheim, Baden-Wurttemberg, Germany), 8(14), 2004973-2004973 (2021-07-27)
Regulatory T cells play a key role in immune tolerance to self-antigens, thereby preventing autoimmune diseases. However, no drugs targeting Treg cells have been approved for clinical trials yet. Here, a chimeric peptide is generated by conjugation of the cytoplasmic
Milica Bozic et al.
Nature communications, 11(1), 1943-1943 (2020-04-25)
Kidney fibrosis is a highly deleterious process and a final manifestation of chronic kidney disease. Alpha-(α)-synuclein (SNCA) is an actin-binding neuronal protein with various functions within the brain; however, its role in other tissues is unknown. Here, we describe the
Jie-Ning Li et al.
Frontiers in cell and developmental biology, 9, 671244-671244 (2021-07-23)
MicroRNAs (miRNAs) are small non-coding RNAs which post-transcriptionally suppress target mRNAs expression and/or translation to modulate pathophyological processes. Expression and function of miRNAs are fine-tuned by a conserved biogenesis machinery involves two RNase-dependent processing steps of miRNA maturation and the
Jenny M Brown et al.
iScience, 24(9), 102944-102944 (2021-08-26)
The capacity of the brain to elicit sustained remission of hyperglycemia in rodent models of type 2 diabetes following intracerebroventricular (icv) injection of fibroblast growth factor 1 (FGF1) is well established. Here, we show that following icv FGF1 injection, hypothalamic
Duo Wang et al.
International immunopharmacology, 84, 106510-106510 (2020-05-04)
Reports show that particulate matter (PM) is related to respiratory and cardiovascular diseases. We previously reported the biological effects of PM in vivo and the endocytosis of PM by primary neutrophils from mice. Cell lines can be used to elucidate

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门